Neurogene (NGNE) Capital Leases (2015 - 2026)

Neurogene (NGNE) reported Capital Leases of $4000.0 for Q1 2026, down 76.47% on a YoY basis from $17000.0 in Q1 2025, and down 20.0% quarter-over-quarter from $5000.0 in Q4 2025.

Neurogene (NGNE) Capital Leases (2015 - 2026) Analysis & Trends

Neurogene has reported Capital Leases for 12 years, with the latest figure at $4000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Capital Leases fell 76.47% year-over-year to $4000.0; the trailing twelve-month figure through Mar 2026 stood at $4000.0 (down 76.47% YoY), and the FY2025 full-year result was $5000.0, down 80.77% from the prior year.
  • Capital Leases for Q1 2026 stood at $4000.0, down from $5000.0 in the prior quarter.
  • The five-year high for Capital Leases was $66000.0 in Q1 2022, with the low at $4000.0 in Q1 2026.
  • Historically, Capital Leases has averaged $26294.1 across 5 years, with a median of $10000.0 in 2022.
  • Annual changes were most pronounced in 2023 — Capital Leases sank 89.39% — and 2024, when it jumped 783.33%.
  • Neurogene's Capital Leases stood at $66000.0 in 2022, then dropped by 1.52% to $65000.0 in 2023, then slumped by 60.0% to $26000.0 in 2024, then plunged by 80.77% to $5000.0 in 2025, then slipped by 20.0% to $4000.0 in 2026.
  • The last three Capital Leases figures came in at $4000.0 (Q1 2026), $5000.0 (Q4 2025), and $7000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Neurogene 216.17 Mn 216.17 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 4,000.00
Dec 31, 2025 5,000.00
Sep 30, 2025 7,000.00
Jun 30, 2025 9,000.00
Mar 31, 2025 17,000.00
Dec 31, 2024 26,000.00
Sep 30, 2024 39,000.00
Jun 30, 2024 53,000.00
Mar 31, 2024 53,000.00
Dec 31, 2023 65,000.00
Sep 30, 2023 5,000.00
Jun 30, 2023 6,000.00
Mar 31, 2023 7,000.00
Dec 31, 2022 66,000.00
Sep 30, 2022 9,000.00
Jun 30, 2022 10,000.00
Mar 31, 2022 66,000.00
Dec 31, 2021 67,000.00
Sep 30, 2021 68,000.00
Jun 30, 2021 68,000.00